Access cutting-edge small cell lung cancer (sclc) treatment through this clinical trial at a research site in Fayetteville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Fayetteville location
Preparing your pre-screening questions…
Access small cell lung cancer (sclc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell lung cancer (sclc) treatment provided free
Check if you qualify for this small cell lung cancer (sclc) clinical trial in Fayetteville, AR
No-Cost Study Care
Local to Fayetteville
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer that has spread widely in the body. To join the study, participants must meet the following conditions: * Be 18 years or older. * Have extensive-stage small cell lung cancer confirmed by lab tests. * Have not received chemotherapy or radiation for this type of lung cancer. * Be in good physical condition and have healthy organs based on medical tests. The study has two parts: * In the first part, researchers will check how safe the study medicine is and how well people tolerate it when given with chemotherapy. * In the second part, they will compare study medicine plus chemotherapy to another approved treatment (atezolizumab plus chemotherapy) to see which works better. Participants will receive the treatment through IV infusions (medicine given directly into a vein). The treatment will be given in repeated time periods called cycles. Some participants will continue receiving the study medicine alone after the initial treatment.
Sponsor: Pfizer
Yes, this clinical trial (NCT07226999) has an active research site in Fayetteville, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for small cell lung cancer (sclc) treatment options in Fayetteville, AR, this clinical trial (NCT07226999) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fayetteville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer (sclc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all small cell lung cancer (sclc) clinical trials near you to find additional studies recruiting in your area.
See all lung cancer clinical trials recruiting in Fayetteville — not just this study.
Browse Lung Cancer Trials in Fayetteville →